WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
Helen Ferns speaks about the new patient treatment centre opening as part of the Christie NHS Foundation Trust in Manchester. This unit will be the largest early clinical trials unit in the world, the largest chemotherapy facility in the UK (increasing treatments from 30,000 to 38,000 a year) and will also contain The Christie Clinic, a new private patients unit run in collaboration with Healthcare America to increase income for NHS services. Ms Ferns explains how the new facility will benefit patients, facilitate drug development, talks about the capacity to offer personalised therapies and discussed the imaging technologies that are available at the centre. There is a high degree of cooperation between the research and chemotherapy teams at the new centre; this is expected to increase the level of staff expertise and consequently improve the quality of care for patients.
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients
Tusamitamab ravtansine versus docetaxel in previously treated advanced nonsquamous NSCLC: Results from phase 3 CARMEN-LC03 trial
Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Amivantamab-lazertinib continue to show benefit as a first-line standard-of-care for EGFR-mutated advanced NSCLC